je.st
news
Tag: secondquarter
U.S. Second-Quarter Growth Revised to 3% in Momentum Boost
2017-08-30 16:11:55| National Real Estate Investor
Gross domestic product rose at a 3% annualized rate from prior quarter (est. 2.7%); revised from initial estimate of 2.6%.
Tags: growth
revised
boost
momentum
Japan second-quarter GDP beats expectations
2017-08-14 09:17:49| BBC News | Business | UK Edition
Domestic demand helped boost second quarter growth in the world's third-largest economy.
Tags: japan
expectations
beats
gdp
US second-quarter growth accelerates to 2.6%
2017-07-28 15:51:55| BBC News | Business | UK Edition
Higher consumer spending and business investment helped to boost the US economy.
Tags: growth
accelerates
secondquarter
Covestro Reports Strong Second-quarter Earnings
2017-07-25 16:43:00| Coatings World Breaking News
Tags: reports
strong
earnings
earnings reports
Merck Announces Second-Quarter 2016 Financial Results
2016-07-29 12:45:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. Second-Quarter 2016 Worldwide Sales Were $9.8 Billion, an Increase of 1 Percent, Including a 2 Percent Negative Impact from Foreign Exchange Second-Quarter 2016 GAAP EPS Was $0.43; Second-Quarter Non-GAAP EPS Was $0.93 Company Updates EPS Guidance: Full-Year 2016 GAAP EPS Range to be Between $1.98 and $2.08; Full-Year 2016 Non-GAAP EPS Range of $3.67 to $3.77 Advanced KEYTRUDA Development Program KEYTRUDA Demonstrated Superior Progression-Free Survival and Overall Survival Compared to Chemotherapy in Patients with Previously Untreated Advanced Non-Small Cell Lung Cancer (NSCLC) Whose Tumors Expressed PD-L1 in KEYNOTE-024 Study Merck Received Positive Opinion from Committee for Medicinal Products for Human Use of the European Medicines Agency for KEYTRUDA for the Treatment of Previously Treated Advanced NSCLC in Patients Whose Tumors Express PD-L1 KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced financial results for the second quarter of 2016. Language: English Contact: MerckMedia:Lainie Keller, 908-236-5036orInvestors:Teri Loxam, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: results
financial
announces
merck
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] next »